{
  "abstract": "Surveillance for cholangiocarcinoma in patients living with large-duct primary sclerosing cholangitis with the aim of diagnosing these cancers early and allowing potentially curative treatment, is suggested in international guidelines. The evidence supporting this approach is limited and this debate presents arguments in favour and against surveillance for cholangiocarcinoma.",
  "authors": [
    {
      "affiliations": [
        "Department of Surgery & Cancer, Imperial College London, London, UK"
      ],
      "name": "Mathew Vithayathil"
    },
    {
      "affiliations": [
        "Leeds Liver Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK",
        "Academic Department of Gastroenterology, Sheffield Teaching Hospitals, Sheffield, UK"
      ],
      "name": "Victoria Knott"
    },
    {
      "affiliations": [
        "Leeds Liver Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK",
        "Leeds Institute for Medical Research, University of Leeds, Leeds, UK"
      ],
      "name": "Ian A Rowe"
    },
    {
      "affiliations": [
        "Hepatology and Gastroenterology Section, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK"
      ],
      "name": "Shahid A Khan"
    }
  ],
  "title": "Debate: pros and cons of surveillance for cholangiocarcinoma in patients with primary sclerosing cholangitis",
  "uid": "1444091f-bc78-5518-944d-0abfe007b967"
}